In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.

Market Analysis and Insights: Global IVD Infectious Diseases Market
The global IVD Infectious Diseases market size is projected to reach US$ 22230 million by 2027, from US$ 16620 million in 2020, at a CAGR of 3.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IVD Infectious Diseases market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IVD Infectious Diseases market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IVD Infectious Diseases market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IVD Infectious Diseases market.

Global IVD Infectious Diseases Scope and Market Size
IVD Infectious Diseases market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IVD Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunochemistry
Molecular Diagnostics

Segment by Application
Clinical Laboratories
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories